NDC51672-4043-01: CLORAZEPATE DIPOTASSIUM TABLETS.
CLORAZEPATE DIPOTASSIUM TABLETS. Key specifications include special_features: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION, primary_container_type: BOTTLE, protective_storage_feature: SECURITY STORAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-153-4377, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| primary_container_type | BOTTLE |
| protective_storage_feature | SECURITY STORAGE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CHLORAZEPATE DIPOTASSIUM TABLETS USP 7.5MG 100S BT |
| NSN | 6505-01-153-4377 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORAZEPATE DIPOTASSIUM TABLETS USP 7.5MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.